Real-time enrollment status for this neoplasms clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:49 AM UTC
| NCT Number | NCT06884618 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 405 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | April 21, 2026 (Apr 21, 2026) |
As of August 28, 2026: Clinical trial NCT06884618 is currently recruiting participants. This phase1 study for neoplasms is actively seeking new participants at 6 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06884618 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06884618 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.